BG103089A - Indoline derivatives useful as 5-ht-2c-receptor antagonists - Google Patents

Indoline derivatives useful as 5-ht-2c-receptor antagonists

Info

Publication number
BG103089A
BG103089A BG103089A BG10308999A BG103089A BG 103089 A BG103089 A BG 103089A BG 103089 A BG103089 A BG 103089A BG 10308999 A BG10308999 A BG 10308999A BG 103089 A BG103089 A BG 103089A
Authority
BG
Bulgaria
Prior art keywords
receptor antagonists
derivatives useful
indoline derivatives
alkyl
relates
Prior art date
Application number
BG103089A
Other languages
Bulgarian (bg)
English (en)
Inventor
Steven Bromidge
Ian FORBES
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103089A publication Critical patent/BG103089A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG103089A 1996-06-20 1999-01-15 Indoline derivatives useful as 5-ht-2c-receptor antagonists BG103089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds
PCT/EP1997/003156 WO1997048699A1 (en) 1996-06-20 1997-06-16 Indoline derivatives useful as 5-ht-2c receptor antagonists

Publications (1)

Publication Number Publication Date
BG103089A true BG103089A (en) 1999-09-30

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103089A BG103089A (en) 1996-06-20 1999-01-15 Indoline derivatives useful as 5-ht-2c-receptor antagonists

Country Status (33)

Country Link
US (1) US6369060B1 (ko)
EP (1) EP0912554B1 (ko)
JP (1) JP2000512306A (ko)
KR (1) KR20000022045A (ko)
CN (1) CN1229408A (ko)
AP (2) AP9801410A0 (ko)
AR (1) AR008243A1 (ko)
AT (1) ATE228514T1 (ko)
AU (1) AU718597B2 (ko)
BG (1) BG103089A (ko)
BR (1) BR9709911A (ko)
CA (1) CA2258240A1 (ko)
CO (1) CO4890847A1 (ko)
CZ (1) CZ420598A3 (ko)
DE (1) DE69717449T2 (ko)
DZ (1) DZ2250A1 (ko)
EA (1) EA001780B1 (ko)
ES (1) ES2187783T3 (ko)
GB (1) GB9612883D0 (ko)
HU (1) HUP9903439A3 (ko)
ID (1) ID19433A (ko)
IL (1) IL127417A0 (ko)
MA (1) MA24214A1 (ko)
NO (1) NO985972D0 (ko)
NZ (1) NZ333229A (ko)
OA (1) OA10944A (ko)
PE (1) PE86698A1 (ko)
PL (1) PL330796A1 (ko)
SK (1) SK282706B6 (ko)
TR (1) TR199802661T2 (ko)
TW (1) TW382015B (ko)
WO (1) WO1997048699A1 (ko)
ZA (1) ZA975415B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3030899A (en) * 1998-02-25 1999-09-15 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
MXPA04005151A (es) 2001-11-28 2004-08-11 Upjohn Co Compuestos terapeuticos.
WO2003076426A2 (en) * 2002-03-04 2003-09-18 Pharmacia & Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
KR20110114664A (ko) 2009-01-16 2011-10-19 메사추세츠 인스티튜트 오브 테크놀로지 자폐 스펙트럼 장애의 진단 및 치료
EP2651403B1 (en) 2010-12-17 2020-12-02 Glaxo Group Limited Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
JPH08500580A (ja) 1992-08-20 1996-01-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼拮抗薬用縮合インドール誘導体
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
ATE197300T1 (de) * 1995-02-02 2000-11-15 Smithkline Beecham Plc Indolderivate als 5-ht rezeptorantagoniste
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EA199900043A1 (ru) 1999-06-24
KR20000022045A (ko) 2000-04-25
AU718597B2 (en) 2000-04-20
SK175298A3 (en) 1999-05-07
CZ420598A3 (cs) 1999-06-16
EA001780B1 (ru) 2001-08-27
PL330796A1 (en) 1999-06-07
DE69717449T2 (de) 2003-10-02
JP2000512306A (ja) 2000-09-19
AP9701037A0 (en) 1997-07-31
HUP9903439A3 (en) 2002-12-28
CA2258240A1 (en) 1997-12-24
ID19433A (id) 1998-07-09
ZA975415B (en) 1998-12-21
GB9612883D0 (en) 1996-08-21
NO985972L (no) 1998-12-18
IL127417A0 (en) 1999-10-28
DE69717449D1 (de) 2003-01-09
OA10944A (en) 2003-02-27
TW382015B (en) 2000-02-11
SK282706B6 (sk) 2002-11-06
EP0912554B1 (en) 2002-11-27
AR008243A1 (es) 1999-12-29
ATE228514T1 (de) 2002-12-15
CO4890847A1 (es) 2000-02-28
AP9801410A0 (en) 1998-12-31
EP0912554A1 (en) 1999-05-06
ES2187783T3 (es) 2003-06-16
AP745A (en) 1999-04-28
NO985972D0 (no) 1998-12-18
US6369060B1 (en) 2002-04-09
PE86698A1 (es) 1999-01-28
TR199802661T2 (xx) 1999-03-22
MA24214A1 (fr) 1997-12-31
CN1229408A (zh) 1999-09-22
DZ2250A1 (fr) 2002-12-18
WO1997048699A1 (en) 1997-12-24
HUP9903439A2 (en) 2000-07-28
NZ333229A (ko) 2000-01-28
AU3260297A (en) 1998-01-07
BR9709911A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
ES2174836T3 (es) Heterrociclos nitrogenados triciclicos condesados como antagonistas de receptor de la sustancia p.
MY118163A (en) Aryl fused azapolycyclic compounds
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ATE251141T1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
AR004320A1 (es) Nuevos compuestos de pirimidina condensados biciclicos; un procedimiento para su preparacion; composiciones farmaceuticas que los contienen y su usocomo agentes terapeuticos, en particular como inhibidores de la tirosina quinasa.
EP0279990A3 (en) Use of heterocyclic derivatives in the treatment of cognitive disorders
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
GR3019490T3 (en) Substituted piperazines as central nervous system agents
BG103089A (en) Indoline derivatives useful as 5-ht-2c-receptor antagonists
DE69409796T2 (de) Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
FR2613364B1 (fr) Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
AR013844A1 (es) Compuestos derivados de 3-oxo-pirido[1,2-a] bencimidazol-4-carboxamida sustituidos en posicion 5 con alquilo que contiene heteroatomo,- y composiciones farmaceuticas que los comprenden.
PE44199A1 (es) Benzo[e]isoindoles y benzo[h]isoquinolinas triciclicos
AR014354A1 (es) Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas.
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
MX9302225A (es) Cicloalquenos y cicloalcanos 1,3-substituidos como agentes del sistema nervioso central.
MX9206635A (es) Cicloalquenos y cicloalcanos 1,3-substituidos como agentes del sistema nervioso central.
IL132344A0 (en) Alkaloid halide salts of swainsonine compositions containing the same and the use thereof
CO4920233A1 (es) Acidos aminobutiricos gamma substituidos como agentes farmaceuticos